Legence Corp. reports today with a striking disconnect at the centre of the story: the Street has spent the past month sharply lifting price targets, yet the stock fell 11% on May 14 alone and has given back nearly 9% on the week heading into the print.
The analyst upgrade wave has been unusually broad and confident. BTIG's Gregory Lewis raised his target from $75 to $120 this morning, hours before the release, maintaining his Buy. Two new Buy initiations arrived late April — Loop Capital at $96 and GLJ Research at $99. Goldman Sachs lifted its target twice in six weeks, landing at $72 on April 16. The consensus mean is now $86.07, barely below yesterday's close of $89. In aggregate, this is a Street that has been chasing the stock higher — which makes yesterday's sharp drop more than usually significant.
Options positioning has shifted toward caution as earnings approach. The put/call ratio climbed to 0.41, running well above its 20-day average of 0.24 — the highest reading of the past year at 0.46 was hit just last week. The z-score of 1.17 is not yet extreme, but the direction is clear: demand for downside protection has risen sharply since early May, after the PCR spent most of April below 0.18.
The short and borrow picture is less charged. Short interest is 5.5% of the free float — meaningful, but down roughly 9% from a month ago. Borrow costs have eased materially, falling about 33% over the past month to just 0.37%. Availability is very loose, meaning there is ample capacity for new short positions if sellers want to add after the release. That backdrop removes most squeeze risk but also signals that short sellers are not loading up ahead of the print.
The bull case rests on record revenue — Q4 hit $737.6 million, up 35% year-on-year — and a $1.5 billion backlog concentrated in high-growth verticals like data centres and healthcare. Bears focus on slipping Engineering & Design revenues, margin vulnerability from fixed-fee contracts, and the risk that organic growth disappoints in a softer macro environment. Blackstone, the company's largest holder at 25% of shares, sold over $831 million worth of stock in April at $54 — well below yesterday's close — framing the current price as a significant premium to where the major shareholder was willing to exit weeks ago.
Today's print is therefore less a referendum on revenue and more a test of whether the margin story holds and organic growth can justify a stock that, even after Thursday's drop, trades at a P/E above 84.
See the live data behind this article on ORTEX.
Open LGN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
